XML 32 R48.htm IDEA: XBRL DOCUMENT v2.4.0.6
EQUITY METHOD INVESTMENT (Details) (USD $)
1 Months Ended 12 Months Ended
Sep. 30, 2012
Nov. 30, 2010
Dec. 31, 2011
Dec. 31, 2010
EQUITY METHOD INVESTMENT        
Proportionate share of ViaGen operating losses     $ 503,000 $ 2,347,000
Trans Ova
       
EQUITY METHOD INVESTMENT        
Maximum proportionate share of contingent commercial milestone payments 2,400,000      
ViaGen
       
EQUITY METHOD INVESTMENT        
Payment to purchase equity interest in ViaGen   23,000    
Ownership interest (as a percent) 40.00% 28.00%    
Amount of loan provided to ViaGen to fund operations   1,500,000    
Amount of loan used to fund prior losses   900,000    
Proportionate share of ViaGen operating losses     $ 503,000 $ 1,447,000
Percentage of potential proceeds receivable 40.00%